tiprankstipranks

Maravai Lifesciences price target lowered to $5 from $7 at Morgan Stanley

Maravai Lifesciences price target lowered to $5 from $7 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Maravai Lifesciences (MRVI) to $5 from $7 and keeps an Equal Weight rating on the shares. Following a “mixed” Q4, the firm maintains an Equal Weight rating pending evidence of sustained top-line recovery despite the stock’s pullback, the analyst tells investors.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue